Total cohort (n = 438) | BCE performed (n = 149) | BCE not performed (n = 289) | p value1 | |
---|---|---|---|---|
Oxytocin infusion | 432 (98.6%) | 149 (100%) | 283 (97.9%) | 0.10 |
Ergometrine | 290 (66.2%) | 127 (85.2%) | 163 (56.4%) | < 0.001 |
Ergometrine-additional dose | 135 (30.8%) | 76 (51.0%) | 59 (20.4%) | < 0.001 |
Misoprostol | 186 (42.5%) | 93 (62.4%) | 93 (32.2%) | < 0.001 |
PgF2α | 10 (2.3%) | 8 (5.4%) | 2 (0.7%) | 0.004 |